Literature DB >> 17877230

Community-acquired pneumonia in Thai patients with systemic lupus erythematosus.

Roongtiva Narata1, Suparaporn Wangkaew, Nuntana Kasitanon, Worawit Louthrenoo.   

Abstract

Infection, particularly pneumonia, is a major cause of morbidity and mortality in patients with systemic lupus erythematosus (SLE). This study was performed to assess the prevalence, causative organisms, and outcomes of community-acquired pneumonia (CAP) in Thai SLE patients, and determine the predicting factors for death. A retrospective chart review of adult SLE patients, age >16 years, seen at the Division of Rheumatology, Chiang Mai University over an 18 year period was carried out. Cases diagnosed with CAP were selected for this study. Of 542 SLE patients, a total of 56 episodes of CAP occurred in 52 patients. Their mean age +/- SD and duration of SLE were 37.98 +/- 11.48 years and 34.99 +/- 54.53 months, respectively. Thirty-three CAP cases (58.9%) occurred within the first year of diagnosis with SLE. The causative organisms identifiable in 40 patients (71.5%) were Mycobacterium tuberculosis in 12, Nocardia spp in 6, Aspergillus spp in 5, Staphylococcus aureus in 3, Pneumocystis carinii, Haemophilus influenzae, Escherichia coli, and Pseudomonas aeruginosa in 2 each, and Acinetobactor baumanii, Burkholderia pseudomallei, and Strongyloides stercoralis in 1 each. The remaining 3 patients had mixed bacterial infection. The overall mortality rate was 26.8%. Use of high dose prednisolone (> or =15 mg/day), and ventilator support were significantly associated with death.

Entities:  

Mesh:

Year:  2007        PMID: 17877230

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  5 in total

1.  Systemic lupus erythematosus and melioidosis.

Authors:  Mohd Jazman Che Rahim; Nurashikin Mohammad; Muhammad Imran Kamaruddin; Wan Syamimee Wan Ghazali
Journal:  BMJ Case Rep       Date:  2019-07-01

2.  Severe pneumonia in patients with systemic lupus erythematosus admitted to the intensive care unit.

Authors:  Bin Zhang; Luzhao Zheng; Yu Huang
Journal:  Z Rheumatol       Date:  2022-03-01       Impact factor: 1.372

Review 3.  Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression.

Authors:  David M Lowe; Molebogeng X Rangaka; Fabiana Gordon; Chris D James; Robert F Miller
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

4.  Effect of Systemic Lupus Erythematosus on the Risk of Incident Respiratory Failure: A National Cohort Study.

Authors:  Jun-Jun Yeh; Yu-Chiao Wang; Jiunn-Horng Chen; Wu-Huei Hsu
Journal:  PLoS One       Date:  2016-09-21       Impact factor: 3.240

5.  Melioidosis in Thailand: Present and Future.

Authors:  Soawapak Hinjoy; Viriya Hantrakun; Somkid Kongyu; Jedsada Kaewrakmuk; Tri Wangrangsimakul; Siroj Jitsuronk; Weerawut Saengchun; Saithip Bhengsri; Thantapat Akarachotpong; Somsak Thamthitiwat; Ornuma Sangwichian; Siriluck Anunnatsiri; Rasana W Sermswan; Ganjana Lertmemongkolchai; Chayada Sitthidet Tharinjaroen; Kanya Preechasuth; Ratchadaporn Udpaun; Poomin Chuensombut; Nisarat Waranyasirikul; Chanihcha Anudit; Surapong Narenpitak; Yaowaruk Jutrakul; Prapit Teparrukkul; Nittaya Teerawattanasook; Kittisak Thanvisej; Alisa Suphan; Punchawee Sukbut; Kritchavat Ploddi; Poolsri Sirichotirat; Bongkoch Chiewchanyon; Kamolchanok Rukseree; Maliwan Hongsuwan; Gumphol Wongsuwan; Pornpan Sunthornsut; Vanaporn Wuthiekanun; Sandy Sachaphimukh; Prapass Wannapinij; Wirongrong Chierakul; Claire Chewapreecha; Janjira Thaipadungpanit; Narisara Chantratita; Sunee Korbsrisate; Apichai Taunyok; Susanna Dunachie; Prasit Palittapongarnpim; Stitaya Sirisinha; Rungrueng Kitphati; Sopon Iamsirithaworn; Wipada Chaowagul; Ploenchan Chetchotisak; Toni Whistler; Surasakdi Wongratanacheewin; Direk Limmathurotsakul
Journal:  Trop Med Infect Dis       Date:  2018-04-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.